Central to AD pathogenesis is the aggregation of amyloid-β (Aβ) peptides, derivatives of amyloid precursor protein (APP) cleavage, implicated in neurodegenerative pathways in AD patients [106,107]. This evidence concerns the gene APP and Alzheimer disease.